1. Genetic and transcriptional landscape of plasma cells in POEMS syndrome
   Yuhei Nagao et al, 2019, Leukemia CrossRef
2. Overexpression of Protocadherin-10 in Transthyretin-Related Familial Amyloidotic Polyneuropathy
   Nádia P. Gonçalves et al, 2016, The American Journal of Pathology CrossRef
3. Protocadherin B9 Is Associated with Human Esophageal Squamous Cell Carcinoma Progression
   Yuto Fujiki et al, 2023, Pathobiology CrossRef
4. Innovative mouse models for the tumor suppressor activity of Protocadherin-10 isoforms
   Irene Kleinberger et al, 2022, BMC Cancer CrossRef
5. Genome-wide analysis toward the epigenetic aetiology of myelodysplastic syndrome disease progression and pharmacoepigenomic basis of hypomethylating agents drug treatment response
   Stavroula Siamoglou et al, 2023, Human Genomics CrossRef
6. Prognostic signature of protocadherin 10 methylation in curatively resected pathological stage I non‐small‐cell lung cancer
   Hiroaki Harada et al, 2015, Cancer Medicine CrossRef
7. Knockdown of REGγ inhibits the proliferation and migration and promotes the apoptosis of multiple myeloma cells by downregulating NF-κB signal pathway
   Shuang Liu et al, 2018, Hematology CrossRef
8. Transcriptome Profiling of Mouse Embryonic Fibroblast Spontaneous Immortalization: A Comparative Analysis
   Jocshan Loaiza-Moss et al, 2024, International Journal of Molecular Sciences CrossRef
9. Epigenetic silencing of protocadherin 10 in colorectal cancer
   Xian Zhong et al, 2017, Oncology Letters CrossRef
10. Protocadherins at the Crossroad of Signaling Pathways
    Anna Pancho et al, 2020, Frontiers in Molecular Neuroscience CrossRef
11. Recent Advances in Phytochemicals and Their Synergistic Role in Multiple Myeloma
    Sharmistha Singh et al, 2019, Phytochemistry: An in-silico and in-vitro Update CrossRef
12. The role of Pcdh10 in neurological disease and cancer
    Yilan Zhen et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef
13. PCDH10 exerts tumor-suppressor functions through modulation of EGFR/AKT axis in colorectal cancer
    Tzu-Ming Jao et al, 2021, Cancer Letters CrossRef
14. Methylation and Expression of Nonclustered Protocadherins Encoding Genes and Risk of Precancerous Gastric Lesions in a High-Risk Population
    Si Wu et al, 2018, Cancer Prevention Research CrossRef
15. PCDH10 inhibits cell proliferation of multiple myeloma via the negative regulation of the Wnt/β-catenin/BCL-9 signaling pathway
    YONGHUI XU et al, 2015, Oncology Reports CrossRef
16. PCDH10 gene inhibits cell proliferation and induces cell apoptosis by inhibiting the PI3K/Akt signaling pathway in hepatocellular carcinoma cells
    Mingxin Ye et al, 2017, Oncology Reports CrossRef
17. The short-term effect of histone deacetylase�inhibitors, chidamide and valproic acid, on�the�NF‑κB�pathway in multiple myeloma cells
    Zhaoyun Liu et al, 2018, International Journal of Molecular Medicine CrossRef
18. Genistein inhibits the proliferation of human multiple myeloma cells through suppression of nuclear factor-κB and upregulation of microRNA-29b
    JIE XIE et al, 2016, Molecular Medicine Reports CrossRef
19. Protocadherin-10 acts as a tumor suppressor gene, and is frequently downregulated by promoter methylation in pancreatic cancer cells
    CHAN QIU et al, 2016, Oncology Reports CrossRef
20. Clinical significance of PCDH10 promoter methylation in diffuse large B-cell lymphoma
    Wenting Huang et al, 2017, BMC Cancer CrossRef